Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cells.
Junttila TT, Li J, Johnston J, et al.
Cancer Research, 74(19), 5561-5571 (2014)
Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E2 release
Chivers JE, et al.
European Journal of Biochemistry, 271(20), 4042-4052 (2004)
Evidence for lipopolysaccharide induced differentiation of RAW264. 7 murine macrophage cell line into dendritic like cells
Saxena RK, et al.
Journal of Biosciences, 28(1), 129-134 (2003)
Impact of integrin-matrix matching and inhibition of apoptosis on the survival of purified human beta-cells in vitro
Ris F, et al.
Diabetologia, 45(6), 841-850 (2002)
Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells
Oak PS, et al.
International Journal of Cancer. Journal International Du Cancer, 131(12), 2808-2819 (2012)